Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | Six Months Ended June 30, | Six Months Ended June 30, | Six Months Ended June 30, |
|---|---|---|---|
| Purchase of certificates of deposit | (15,875) | (19,184) | |
| Purchase of available-for-sale securities | (2,032) | (11,224) | |
| Proceeds of available-for-sale securities | 13,068 | 11,699 | |
| Purchase of property and equipment | (440) | (457) | |
| Proceeds from sale of equipment | 13 | 19 | |
| Proceeds from maturity of certificates of deposit | 12,997 | 23,190 | |
| Net cash provided by investing activities | 6,702 | 3,321 | |
| Financing Activities |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s capex?
- Gyre Therapeutics, Inc. (GYRE) reported capex of $262K in Q2 2026.
- How has Gyre Therapeutics, Inc.'s capex changed year-over-year?
- Gyre Therapeutics, Inc.'s capex decreased by 21.8% year-over-year, from $335K to $262K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s capex?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s capex has grown at a -38.0% compound annual growth rate (CAGR), from $4.99M to $1.19M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Gyre Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude